Author Archive: Tracy Cooley

Tracy Cooley

Tracy serves as the Director of Events Communications and handles all communications for BIO’s events and emerging company policy issues. She loves blogging and podcasting on all things biotech and believes in the great potential of the industry, looking for every opportunity to spread the message far and wide. Nearly everyone in her family is a golfer, and as such, she has what many people have called a “natural” swing. Sometimes she even hits the ball. Tracy just finished her ninth marathon, and has nearly mastered the skill of one-foot-in-front-of-the-other (usually, sometimes the laces get in the way). The joy of her life is her five-year-old daughter Josephine.

Latest Posts

National Traceability System Moves into Implementation

5616315608_dd9b7a55dd_b

Last week, President Obama signed into law the Drug Quality and Security Act (H.R. 3204), which created a single, uniform and national solution to safeguard the nation’s pharmaceutical supply chain against criminal counterfeiting. Inside Health Policy’s Alaina Busch highlighted implementation plans in this November 20 story, “Drug Security Bill Ushers In Compounder Market Shift, 10-Year Effort To Implement Rx Tracing,” which can be accessed here with a subscription. Below are details on implementation based on Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Emerging Company Policy Deconstructed: Small Cap Liquidity Reform Act (H.R. 3448)

87881842

In a nutshell: This bill, sponsored by Reps. Sean Duffy (R-WI) and John Carney (D-DE), will spur capital formation by increasing liquidity for emerging growth companies, including biotech innovators, that trade on the public market. Why you should care: Under current U.S. Securities and Exchange Commission (SEC) rules, all securities on the public market are priced in $0.01 increments. This minimum trading increment is known as the “tick size.” The switch to the standard tick Read More >

Business and Investments  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

Innovation Act Threatens Biotech Innovation

AB23475

BIO has grave concerns regarding the Innovation Act (H.R. 3309), as reported by the House Judiciary Committee. The Innovation Act was introduced with the goal of furthering patent system reform, particularly with respect to patent-related litigation. We support increased transparency and oppose abusive litigation tactics. However, provisions in the Act remain overly broad in important respects and, if ultimately enacted, would continue to result in too many unintended and unknowable consequences for innovators who rely on the Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , ,

Children in Philippines Receive Vaccines Against Measles, Polio

Vaccination

The Government of the Philippines with support from UNICEF, the World Health Organization (WHO), and other partners recently announced a mass campaign to vaccinate more than 30,000 children against measles and polio in typhoon-hit Tacloban. They also received Vitamin A supplements to help improve their immunity against infections. More than 5,000 people were killed and more than 1,600 people are missing two weeks after Typhoon Haiyan swept through the Philippines. More than a million homes Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

Obama Launches Initiative Aimed at Curing HIV

President Obama

Today, the Obama administration announced that it is shifting $100 million into research efforts aimed at curing HIV. The initiative is aimed at developing new therapies. “The United States should be at the forefront of the discoveries how to put HIV in long-term remission without requiring lifelong therapies. Or, better yet, eliminate it completely,” President Obama said. The president was less specific about support for programs aimed at treating and preventing HIV/AIDS globally. The U.S. Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , ,